Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.

about

Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.

Item

http://www.wikidata.org/entity/Q47657861

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.

@en

Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.

@nl

type

Item

label

Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.

@en

Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.

@nl

prefLabel

Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.

@en

Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.

@nl

P1476

Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.

@en

P2093

Ashwin Nathan

http://www.w3.org/2001/XMLSchema#string

Jay Giri

http://www.w3.org/2001/XMLSchema#string

Mayur M Contractor

http://www.w3.org/2001/XMLSchema#string

Rahul R Goli

http://www.w3.org/2001/XMLSchema#string

Sony Tuteja

http://www.w3.org/2001/XMLSchema#string

Taisei Kobayashi

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials

Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014

Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials

Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis

Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis

P2888

s11883-017-0698-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11883-017-0698-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29103068

http://www.w3.org/2001/XMLSchema#string